Xarelto Bleeding Lawsuit Attorneys At Southern Med Law Continue To Evaluating Legal Claims On Behalf of Patients Who Suffered Brain Bleeds, Were Hospitalized for Transfusions or Died, Allegedly Due to Complications Associated with the Blood Thinner.
The Xarelto bleeding lawsuit attorneys at Southern Med Law look forward to the start of bellwether trials involving Xarelto bleeding complaints. According to court records there will be four bellwether trials beginning on February 6, 2017. The subsequent trials will be convened starting on March 13, 2017, April 24, 2015, and May 30, 2015. Xarelto lawsuits allege uncontrolled bleeding, brain bleeds and other Xarelto complications, including internal bleeding episodes that resulted in hospitalization for transfusion or death. (In Re: Xarelto Products Liability Litigation, No. 2592)
“We are extremely pleased that Xarelto bleeding lawsuits will begin going to trial in 2017,” says François Blaudeau , the founder of Southern Med Law. “The results of these trials could provide some clues into how Xarelto lawsuits involving similar allegations and injuries could be decided.”
Xarelto was launched on the U.S. market in 2011, and is now approved to reduce the risk of strokes, deep vein thrombosis (DVT), pulmonary embolism (PE), and blood clots in patients who have undergone hip or knee replacement surgery. Its approved indications also include the prevention of blood clots in people with atrial fibrillation, as well as the treatment of DVT and PE.
[fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, December 2014]
Well over 2,000 Xarelto lawsuits have been filed in the Eastern District of Louisiana since the federal Xarelto litigation was established in December 2014. All of the cases were filed on behalf of individuals who allegedly suffer brain bleeds and other Xarelto complications, including internal bleeding episodes that resulted in hospitalization for transfusion or death. Plaintiffs accuse the drug’s manufacturers of failing to provide doctors and patients with adequate warnings about these risks. They also charge that sales of the Xarelto were driven by misleading promises that the medication was superior to warfarin, a blood thinner that has been on the market for nearly 60 years. Among other things, the complaints note that there is no approved antidote to treat the internal bleeding that is sometimes associated with Xarelto. However, warfarin bleeding can be easily ended with the administration of vitamin K.
Federal Xarelto bleeding lawsuits were consolidated in the Eastern District of Louisiana in order to improve judicial efficiency and preserve the resources of the court, witnesses and parties. The multidistrict litigation process prevents duplicative discovery and inconsistent court rulings among a large number of cases sharing similar allegations of fact.
As both an attorney and practicing physician, Southern Med Law’s Dr. François Blaudeau possesses a unique understanding of the medical and legal questions relating to Xarelto lawsuits. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact the Firm as soon as possible to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by calling Southern Med Law today, at 205-547-5525.
Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203